Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Brian W. Loggie

Dr. Brian W. Loggie

Chief, Division of Surgical Oncology

Dr. Brian Loggie ventured into uncharted waters when in the 1990s he pioneered a mesothelioma treatment often referred to as heated intraperitoneal chemotherapy or HIPEC.

Get in touch
Jump to a Topic:

About Brian W. Loggie

  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Research Excellence icon

    Excellence in Research

  • Mesothelioma Pioneer icon

    Mesothelioma Pioneer

  • Team Leader icon

    Team Leader

  • 20+ Years of Experience icon

    20+ Years of Experience

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

It was early in Loggie’s medical career that he helped develop the new cancer treatment that combined surgery with the application of heated chemotherapy drugs. The benefits were immediate. The heat made the drugs more effective in killing the various kinds of cancer. As a result, the procedure is now widely used.

Almost 20 years later, he was taking chances again – and seeing immediate results.

Loggie, professor of surgery and director of the Cancer Biology Program at Creighton University Medical Center in Omaha, Nebraska, led a team of doctors and nurses to Haiti immediately following the devastating earthquake of 2010.

The team was in Haiti for 11 days, working 14-hour shifts of trauma surgery under harsh, often deplorable conditions. They repaired orthopedic injuries, treated open and infected fractures, and amputated limbs, all to save lives.

Loggie returned with a new enthusiasm for his practice, treating and studying peritoneal carcinomatosis and peritoneal mesothelioma.

Doctor talking to patients

Get the Best Treatment

Get help connecting with Dr. Loggie and find the treatment that's best for you.

Get Help Now

Focus on Peritoneal Mesothelioma

Loggie has authored or co-authored many articles and papers detailing treatments he has developed, many detailing the research of mesothelioma.

Peritoneal mesothelioma is a rare form of the disease, representing just 20 percent of all mesothelioma cases. It develops in the lining of the abdominal cavity and is directly related to the inhalation or ingestion of asbestos.

Loggie earned his medical degree from McGill University, in Montreal, Canada. His post-graduate training included an internship with the Department of Surgery at Montreal General Hospital in Montreal, where he later did his residency.

Quick Fact:

Before Dr. Loggie joined the team at Creighton University School of Medicine, the hospital had no Division of Surgical Oncology – Loggie founded the program in 2002.

Dr. Loggie’s Publications

Loggie’s publications focus on malignant peritoneal mesothelioma and other peritoneal cancers, as well as treatment methods for these illnesses. Loggie’s articles have been published in journals such as the Annals of Surgical Oncology and the World Journal of Surgical Oncology.

See More Top Mesothelioma Doctors

Disclaimer: Dr. Brian W. Loggie has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Black, C. (2007, May 15). Taking on the rarest of cancers, and beating the odds. Retrieved from:
  2. Crieghton University. (n.d.). Brian W. Loggie, MD. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 31, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now